TII

Last reported Earnings history refreshes daily; a new report appears within about 2 daysAbout this data

Next report

Nov 11 2026in 35 days

EPS estimate

($0.02)

Revenue estimate

$25M

EPS beats

4 of last 11

EPS surprise

2024: -3512.2%2024: -453.9%2024: 249.2%2024: -798.5%2025: 1515.4%2025: -27.6%2025: 1.5%2025: -80.0%2026: -0.81%2026: -366.1%2026: 359.1%
Mar 22 2024Aug 12 2026
ReportedEPS estEPS actualSurpriseRevenue estRevenue actualSurprise
Aug 12 2026($0.02)$0.05+359.1%$18M$25M+40.4%
May 13 2026($0.03)($0.14)-366.1%$20M$19M-2.6%
Mar 19 2026($0.01)($0.01)-0.8%$21M$25M+17.3%
Nov 5 2025$0.00$0.00-80.0%$21M$17M-20.4%
Aug 11 2025$0.00$0.00+1.5%$16M$17M+4.4%
May 14 2025$0.00$0.00-27.6%$16M$16M-2.0%
Mar 20 2025$0.01$0.13+1515.4%—$26M—
Nov 12 2024$0.01($0.06)-798.5%—$8M—
Aug 15 2024$0.01$0.03+249.2%—$18M—
May 14 2024$0.01($0.03)-453.9%—$12M—
Mar 22 2024($0.00)($0.08)-3512.2%—$11M—

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+15.20%
EPS—
FY2028
Rev-4.78%
EPS—
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028E
Revenue Avg$90M$104M$99M
Low$89M$102M$98M
High$92M$106M$101M
EBITDA Avg$1M$3M$5M
Low$917,944$3M$5M
High$1M$4M$5M
EBIT Avg$-5M$-3M$-2M
Low$-5M$-3M$-2M
High$-4M$-3M$-2M
Net Income Avg$-8M$-6M$-5M
Low$-8M$-6M$-6M
High$-8M$-6M$-5M
EPS Avg$-0.09$-0.07$-0.06
Low$-0.09$-0.07$-0.06
High$-0.09$-0.07$-0.06
Analysts (Rev / EPS)1 / 11 / 11 / 1
Quarterly
MetricQ4 2026Q1 2027Q2 2027Q3 2027Q4 2027Q1 2028Q2 2028Q3 2028
Revenue Avg$27M$23M$28M$26M$27M$24M$25M$25M
Low$27M$23M$28M$26M$27M$24M$25M$25M
High$27M$23M$28M$26M$27M$24M$25M$25M
EBITDA Avg$612,864———————
Low$612,864———————
High$612,864———————
EBIT Avg$-798,111———————
Low$-798,111———————
High$-798,111———————
Net Income Avg$-1M———————
Low$-1M———————
High$-1M———————
EPS Avg$-0.01———————
Low$-0.01———————
High$-0.01———————
Analysts (Rev / EPS)1 / 11 / —1 / —1 / —1 / —1 / —1 / —1 / —
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.